There are 449 resources available
125P - Preliminary analysis on safety of the DEDALUS phase II trial: Induction chemo-durvalumab followed by reduced-dose radiotherapy and maintenance durvalumab for patients with unresectable stage III NSCLC
Presenter: Andrea Riccardo Filippi
Session: Poster Display session
126P - Adjuvant aumolertinib for resected EGFR-mutated stage IA2-IIIA non-small cell lung cancer: Updated results from a multiple-center real-world experience
Presenter: Qingyi Zhang
Session: Poster Display session
127P - Waning effect of adjuvant EGFR TKIs in resected EGFR-mutated (EGFR-m) NSCLC: A systematic review and meta-analysis of randomized clinical trials (RCTs)
Presenter: Martina Imbimbo
Session: Poster Display session
128TiP - A phase II, two parallel group study of neoadjuvant and adjuvant targeted treatment in NSCLC with BRAF V600 or MET exon 14 mutations
Presenter: Shen Zhao
Session: Poster Display session
129P - FDG PET imaging of symptomatic chest wall myositis following stereotactic body radiation therapy (SBRT) for patients with early stage cell lung cancer
Presenter: Maria Werner-Wasik
Session: Poster Display session
130P - Whole-body PET imaging to study bone metabolism in pre- and post-treatment lung cancer patients
Presenter: Rucha Ronghe
Session: Poster Display session
131P - FDG PET-CT as an imaging biomarker in predicting the molecular profile of treatment-naïve NSCLC
Presenter: Abhishek Palsapure
Session: Poster Display session
132P - Enhanced lung nodule malignancy prediction through clinical integration in a deep-learning radiomic model
Presenter: Antoni Rosell
Session: Poster Display session
133P - Development of CT image-based atelectasis simulation and non-invasive lung nodule localization system
Presenter: Jinwook Hwang
Session: Poster Display session
134P - Predictors of success and complications in electromagnetic navigation bronchoscopy of peripheral lung lesions: A retrospective cohort study
Presenter: David Lang
Session: Poster Display session